GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) is a publicly traded Healthcare sector company. As of July 3, 2026, GSK trades at $53.63 with a market cap of $104.99B and a P/E ratio of 0.00. GSK moved +4.60% today. Year to date, GSK is +8.12%; over the trailing twelve months it is +39.34%. Its 52-week range spans $31.72 to $61.70. Analyst consensus is buy with an average price target of $68.55. Rallies surfaces GSK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GSK moved +4.60% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $53.63 |
| Market Cap | $104.99B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.46% |
| 52-Week High | $61.70 |
| 52-Week Low | $31.72 |
| Volume | 3.64M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover GSK: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $68.55.